In this podcast, our correspondent Dr Rachel Giles talks about 5 presentations held at the American Academy of Dermatology Virtual Meeting Experience (AAD VMX), held 23-25 April 2021. The topics discussed are:
- Lipoff J, Jones E, Tejasvi T, Han G. Lessons on Teledermatology From COVID-19 and Planning the Future, Session U003. AAD VMX 2021, 23-25 April.
- Draelos Z. Maskne: the side effects of facial masks during the COVID-19 pandemic. AAD VMX 2021, 23-25 April.
- Lio P, et al. Efficacy and Safety of Crisaborole in Patients With Mild-to-Moderate Atopic Dermatitis With and Without Comorbid Allergies or Asthma. Poster 26304. AAD VMX 2021, 23-25 April.
- Ellen K. Visible light activated topical hypericin ointment in CTCL: FLASH study results. Session S033: Late breaking abstracts. AAD VMX 2021, 23-25 April.
- Lee K. Laser- and light-based treatments for acne, session F002: Acne and rosacea – new developments. AAD VMX 2021, 23-25 April.
Posted on
Previous Article
« EHRA 2021 Highlights Podcast Next Article
Primary and recurrent breast tumors may have different HER2 status »
« EHRA 2021 Highlights Podcast Next Article
Primary and recurrent breast tumors may have different HER2 status »
Table of Contents: AAD 2021
Featured articles
Letter from the Editor
Late-Breaking Abstracts
Small molecule effective in moderate-to-severe psoriasis
Bruton’s tyrosine kinase inhibition promising for pemphigus vulgaris
Bimekizumab superior to secukinumab in psoriasis
Etrasimod – a new mode of action for treatment of atopic dermatitis
Women at higher risk for dermatologic side effects during immunotherapy
Novel easy-to-use foam formulation clears scalp psoriasis in one-third of patients
Anti-cholinergic gel demonstrates superior long-term tolerability and efficacy in axillary hyperhidrosis
Psoriasis – The Beat Goes On
Psoriasis: The treatment armamentarium continues to grow
Psoriasis management in times of COVID-19: the knowledge is growing steadily
Lower burden of high-risk atherosclerotic plaques in psoriasis patients treated with biologics
COVID-19: What Dermatologists Need to Know
Psoriasis and hidradenitis suppurativa during COVID-19: keep calm and carry on
COVID-19 in children – cutaneous involvement is common
Cutaneous reactions after COVID-19 vaccination: an update
Novel Developments in Sun Protection
Sunless tanning and other developments in sun protection
What Is Hot in Atopic Dermatitis
Comorbidity is common in adult and paediatric atopic dermatitis patients
Significant improvements in the system armamentarium for AD treatment
Topical pan-JAK inhibitor cream safe and efficacious in atopic dermatitis
Hairy Matters – What Is New in Alopecia
Allergies: an underrated factor in alopecia pathogenesis
Botulinum toxin A: a contradictory role in hair loss
Platelet-rich plasma in androgenetic alopecia – hype or hope?
Acne – New Developments
New therapeutic options add value to current acne treatment
Nicotinamide and probiotics can support acne therapy
Pearls of the Posters
Related Articles
September 4, 2019
Ixekizumab improves signs and symptoms in TNFi-naïve PsA patients
November 30, 2021
Guselkumab boosts response in resistant psoriatic arthritis
© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy
HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com